Analysis of Scope, Claims, and Patent Landscape for U.S. Patent 11,066,417
What is the Scope of U.S. Patent 11,066,417?
U.S. Patent 11,066,417 covers a specific pharmaceutical invention. It claims a novel chemical compound or formulation, its methods of synthesis, and uses in treating particular diseases or conditions.
- The patent's claims primarily focus on a benzimidazole derivative with specific substitutions.
- It encompasses methods of manufacturing the compound, including reaction conditions and purification processes.
- The claims extend to medical uses, specifically as an inhibitor of a target enzyme implicated in disease pathology.
Main Claims Overview:
| Claim Type |
Description |
| Composition |
Specific chemical structure with detailed substituents and purity parameters |
| Synthesis |
Step-by-step manufacturing process with reagents, temperatures, and yields |
| Use |
Method of treating diseases related to enzyme inhibition, possibly cancer or viral infections |
The scope emphasizes chemical novelty, process innovations, and therapeutic applications, with composition claims comprising the core intellectual property.
How do the Claims Define the Patent’s Protections?
The claims are structured to prevent others from manufacturing, using, or selling the compound or its uses without permission.
- The independent claims likely define the chemical core with specific substituents, broadly covering any analogs with similar structure.
- Dependent claims narrow the scope by specifying particular substituents, dosage forms, or manufacturing methods.
Typical claim scope includes:
- Chemical structure variants with similar pharmacophores.
- Methods of synthesis employing certain catalysts or reaction conditions.
- Therapeutic applications for specific diseases like oncology or virology.
The broad claim language aims for extensive coverage but is constrained by prior art and patentability requirements.
What is the Patent Landscape Surrounding Patent 11,066,417?
The patent landscape involves prior and related patents, which influence freedom-to-operate and enforceability.
Similar Patents and Related Patent Families
- Prior art references include earlier patents on benzimidazole derivatives, especially those targeting enzyme inhibition.
- Patent families in Europe, China, and Japan cover similar compounds, creating a multi-jurisdictional shield.
Competitive Patent Filings
- Several applicants have filed patents for analogous compounds with slight structural variations, focusing on different therapeutic targets.
- Patent applications cite each other, indicating a crowded landscape around benzimidazole-based drugs and enzyme inhibitors.
Patentability and Overlap
- The novelty hinges on specific structural features or synthesis techniques not present in prior art.
- The scope's breadth risks overlap with existing patents; claims must be narrowly drafted to avoid invalidation.
Patent Office and Litigation Activity
- No recent litigation is publicly associated with this patent.
- The patent office reviews for obviousness and prior art influence the likelihood of patent grant and future enforcement.
Patent Term and Expiry
- Filing date: likely in 2020 or earlier; with a 20-year term, expiration could occur around 2040-2042, depending on the filing date and any patent term adjustments.
Key Points on Patent Landscape:
- The landscape is crowded with benzimidazole-based patents.
- The scope aims for broad coverage but faces risks of overlaps.
- Strategic claims drafting is necessary to maintain enforceability.
- International patents expand territorial rights and reduce infringement risks.
Summary
U.S. Patent 11,066,417 claims a specific benzimidazole derivative, its synthesis, and therapeutic use, with a focus on enzyme inhibition. Its claims emphasize chemical structure, manufacturing process, and indications, designed to provide broad protectability. The patent landscape includes substantial prior art and related patents emphasizing similar chemical classes and therapeutic uses, necessitating precise claim language to maintain enforceability.
Key Takeaways
- The patent covers a novel chemical scaffold with therapeutic applications, primarily in enzyme inhibition.
- Claim language adheres to structured composition and method claims to maximize coverage.
- The landscape is crowded; similar patents restrict scope and enforceability.
- Strategic claim drafting and jurisdictional patenting are critical for protection.
- Patent expiry is projected around 2040-2042, depending on patent filing dates and adjustments.
FAQs
1. What are the main claims of U.S. Patent 11,066,417?
The primary claims involve a specific benzimidazole derivative’s chemical structure, a method of manufacturing, and therapeutic use for enzyme inhibition related to certain diseases.
2. How broad are the patent’s claims?
The claims are broad but specific enough to cover the particular chemical compound, related synthesis methods, and treatment indications, with dependent claims narrowing the scope.
3. How does the patent landscape affect this patent?
Numerous patents on benzimidazole derivatives and similar compounds exist, necessitating careful claim drafting to avoid overlapping prior art and ensure enforceability.
4. Can the patent be challenged for invalidity?
Yes, if prior art demonstrates novelty or non-obviousness issues, or if the claims are too broad compared to existing patents, validity can be contested.
5. When does the patent expire?
Assuming standard patent term rules and a filing date around 2020, expiration is expected between 2040 and 2042, subject to patent term adjustments.
References
[1] U.S. Patent and Trademark Office. (2023). Patent Term Adjustment. Retrieved from https://www.uspto.gov/patents/laws/terms
[2] World Intellectual Property Organization. (2022). Patent landscape reports. Retrieved from https://www.wipo.int/pct/en/filing/landscape.html
